DMEMEDS shared post via Reuters: U.S. to test immunotherapy drugs on newly diagnosed brain tumors

CHICAGO (Reuters) - U.S. researchers are finalizing plans to test two immunotherapy drugs made by Bristol-Myers Squibb Co on patients newly diagnosed with the most common form of deadly brain tumors in adults. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/h6owVY3PMdg/story01.htm

Read More